Olanzapine/risperidone and diabetes risk
Lee, D.W.; Fowler, R.B.
Journal of Clinical Psychiatry 64(7): 847-8; Author Reply 848
2003
ISSN/ISBN: 0160-6689 PMID: 12934988 Document Number: 564572
Document emailed within 1 workday
Related Documents
Kim, K.; Aas, E. 2011: Cost-effectiveness analysis of olanzapine and risperidone in Norway Journal of Mental Health Policy and Economics 14(3): 125-135Klebovich, A.ás.; Reszegi, C.A.; Zelkó, R.án. 2004: Utilization study of clozapine, olanzapine and risperidone in Hungary Acta Pharmaceutica Hungarica 74(4): 233-236
Gram, L.F. 2000: Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine Ugeskrift for Laeger 162(13): 1914-1915
Kongsakon, R.; Leelahanaj, T.; Price, N.; Birinyi-Strachan, L.; Davey, P. 2005: Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol Journal of the Medical Association of Thailand 88(9): 1267-1277
Belli, H.; Sertbas, Y.; Bayik, Y. 2005: Olanzapine-induced diabetes due to pancreatitis Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 24(6): 273
Cohen, D. 2005: Diabetes mellitus during olanzapine and quetiapine treatment in Japan Journal of Clinical Psychiatry 66(2): 265-6; Author Reply 266-7
Haslemo, T.; Refsum, H.; Molden, E. 2011: The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapine British Journal of Clinical Pharmacology 71(4): 611-615
Borison, R.L. 1996: Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone Dosing Clinical Therapeutics 18(4): 592-607; discussion 591
Chhatterpal, P.; Avsathi, R.K. 2020: Assessment of Diabetes Risk Using Indian Diabetes Risk Score (IDRS) in Medicine out Patient at Tertiary Care Hospital Journal of the Association of Physicians of India 68(1): 45
Lipkovich, I.; Jacobson, J.G.; Caldwell, C.; Hoffmann, V.P.; Kryzhanovskaya, L.; Beasley, C.M. 2009: Early predictors of weight gain risk during treatment with olanzapine: analysis of pooled data from 58 clinical trials Psychopharmacology Bulletin 42(4): 23-39
Qiao, Q.; Lindstrom, J.; Valle, T.; Tuomilehto, J. 2002: Risk factors contributing to the development of diabetes in subjects free of diabetes at baseline Diabetologia 45(Suppl 2): A 104
Domínguez-Vigo, P.; Álvarez-Silvares, E.; Alves-Pérez M T; Domínguez-Sánchez, J.; González-González, A. 2016: Incidence and clinical risk factors for the development of diabetes mellitus in women with previous gestational diabetes Ginecologia y Obstetricia de Mexico 84(4): 228-242
Schneider, H.; Ziegelasch, H.J. 1981: The cardiovascular risk profile in patients with disorders of glucose tolerance (borderline diabetes) dependent on the heredity of the diabetes Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 36(7): 241-243
Davis, T.M.; Millns, H.; Stratton, I.M.; Holman, R.R.; Turner, R.C. 1999: Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29 Archives of Internal Medicine 159(10): 1097-1103
Hagström, B. 2002: Opportunistic screening for diabetes in primary health care. Life style changes can prevent diabetes mellitus among individuals at risk Lakartidningen 99(16): 1852
Aponte, J. 2009: Diabetes risk factors in Mexican Americans with diabetes Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 18(5): 265-71 301; Quiz 272
1998: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group Bmj 317(7160): 713-720
Keesukphan, P.; Chanprasertyothin, S.; Ongphiphadhanakul, B.; Puavilai, G. 2007: The development and validation of a diabetes risk score for high-risk Thai adults Journal of the Medical Association of Thailand 90(1): 149-154
Peng, J.; Xiong, J.-F.; Zhou, H.; Cheng, J.-Q.; Zhang, D.; Shi, L.ü-Y. 2004: The control study on risk factors of high-risk population in diabetes Zhonghua Liu Xing Bing Xue Za Zhi 25(6): 506-508
Jongsareejit, A.; Potisat, S.; Krairittichai, U.; Sattaputh, C.; Arunratanachote, W. 2013: The Thai DMS Diabetes Complications (DD.Comp.) project: prevalence and risk factors of diabetic retinopathy in Thai patients with type 2 diabetes mellitus Journal of the Medical Association of Thailand 96(11): 1476-1482